FDA-approved Immune & defense

Polymyxin B / Colistin

Polymyxin B / Colistin is a polymyxin antibiotic. It is filed in this library under immune & defense, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA.

Regulatory status

Polymyxin B / Colistin has an FDA-approved product on the U.S. market, marketed as Neomycin And Polymyxin B Sulfates And Hydrocortisone under application ANDA064053.

The current label is held by Remedyrepack Inc.

From the FDA label

What Polymyxin B / Colistin is approved to treat

INDICATIONS AND USAGE For the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics..Quoted from the FDA-approved prescribing information

The evidence

What has actually been published

One source on Polymyxin B / Colistin, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on immune & defense

Not sure what applies to you?

A 60-second questionnaire, reviewed by a U.S.-licensed physician.

Find my protocol

Educational reference only. This page explains what has been published about Polymyxin B / Colistin. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides